Usability and Acceptability Study of the P-STEP Mobile Application
| Condition | Asthma, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Coronary Heart Disease |
|---|---|
| Phase | N/A |
| Sponsor | University of Leicester |
| Status | Completed |
| Enrollment | 178 participants |
| Interventions | P-STEP Mobile Application |
| Start date | Aug 23, 2023 |
| Completion date | Feb 1, 2024 |
| Results posted | May 1, 2026 |
Summary
Assess the usability and acceptance of the P-STEP app, through allowing participants with specific chronic conditions to pilot the app for 12-weeks.
System Usability Scale
| 6-weeks | 57.92 ± 20.12 score on a scale |
|---|---|
| 12-week | 61.68 ± 22.09 score on a scale |
Open in BENITIONS View on ClinicalTrials.gov
Other trials for this condition
- Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and — University of Tennessee Graduate School of Medicine
- Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster — Chiesi Farmaceutici S.p.A.
- Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®T — Chiesi Farmaceutici S.p.A.
- Tiotropium/Salmeterol Inhalation Powder in COPD — Boehringer Ingelheim
- Risk Factors, Costs, and Impacts of ED Boarding — University of Maryland, Baltimore
- Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructiv — United Therapeutics